Journal of Hematology & Thromboembolic Diseases
Open Access

Ulehlova J

Publications

• Research Article
  Detection of Anti-Domain I β-2 Glycoprotein I Antibodies as New Potential Target in Antiphospholipid Syndrome Diagnosis
  Author(s): Slavik L, Janek D, Ulehlova J, Krcova V, Hlusi A and Prochazkova J Slavik L, Janek D, Ulehlova J, Krcova V, Hlusi A and Prochazkova J
  
  Anti-cardiolipin antibodies (ACL) and anti-β-2-glycoprotein I antibodies (anti-2GPI) represent two out of three laboratory criteria for detection of antiphospholipid syndrome (APS). The domain I (DI) in anti-β-2-glycoprotein I is a new target for better identification of antibodies and may be associated with thrombotic risk in antiphospholipid syndrome. Anti-β2GPI antibodies specifically reacting with DI have a particular clinical importance being more commonly detected among patients with APS and other autoimmune diseases. This observation implies that compared with antibodies targeting the whole molecule, anti-DI antibodies have higher specificity for APS. Routine testing for anti- DI antibodies in clinical practice can be used for an easy differentiation of subjects carrying clinically meaningful anti- β2GPI antibodies from those individuals with a benign.. View More»
  DOI: 10.4172/2329-8790.1000276

  Abstract PDF

Relevant Topics